POSA77 Radiofrequency-Based Renal Denervation for Treatment-Resistant Hypertension in Italy: A Budget Impact Analysis

Abstract

Blood pressure (BP) reduction in uncontrolled hypertension (HTN) is associated with reduced risk for cerebro-cardiovascular (CV) events and end-stage renal-disease (ESRD). The safety and efficacy of catheter-based percutaneous renal denervation (RDN) for reducing BP has been demonstrated in patients with uncontrolled HTN, including so-called “treatment resistant” hypertension (trHTN)(uncontrolled BP despite prescription of ≥ 3 antihypertensive drugs). We assessed the economic impact of RDN in trHTN from the Italian healthcare (NHS) perspective, considering the potential economic benefits through avoidance of potential CV events and ESRD.